SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-20-001748
Filing Date
2020-05-27
Accepted
2020-05-27 13:47:15
Documents
65
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT canna_10k-123119.htm 10-K 587730
2 CERTIFICATION canna_ex3101.htm EX-31.1 9793
3 CERTIFICATION canna_ex3102.htm EX-31.2 9563
4 CERTIFICATION canna_ex3200.htm EX-32 4247
  Complete submission text file 0001683168-20-001748.txt   3140299

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20191231.xml EX-101.INS 412508
6 XBRL SCHEMA FILE cpmd-20191231.xsd EX-101.SCH 37570
7 XBRL CALCULATION FILE cpmd-20191231_cal.xml EX-101.CAL 58528
8 XBRL DEFINITION FILE cpmd-20191231_def.xml EX-101.DEF 161690
9 XBRL LABEL FILE cpmd-20191231_lab.xml EX-101.LAB 276270
10 XBRL PRESENTATION FILE cpmd-20191231_pre.xml EX-101.PRE 237359
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27055 | Film No.: 20914597
SIC: 2834 Pharmaceutical Preparations